Fosfomycin, Applying Known Methods and Remedies to A New Era
Open Access
Abstract
The exponential increase in the numbers of isolates of Carbapenem-Resistant Enterobacteriaceae (CRE) creates the need for using novel therapeutic approaches to save the lives of patients. Fosfomycin has long been considered a rational option for the treatment of CRE to be used as part of a combined therapy scheme. However, the assessment of fosfomycin susceptibility in the laboratory presents a great challenge due to the discrepancies found between different methodologies. Thus, our goal was to evaluate fosfomycin susceptibility in a group of 150 Enterobacteriaceae bacterial isolates using agar dilution as the gold standard technique to compare the results with those obtained by disk diffusion. We found a fosfomycin susceptibility of 79.3% in general terms. By comparing both methodologies, we reported a categorical agreement of 96% without Very Major Errors (VMEs) or Major Errors (MEs) and 4% of minor Errors (mEs). Our results suggest that fosfomycin could provide a rational alternative treatment for those patients that are infected by a Multidrug-Resistant (MDR) microorganism that is currently untreatable and that the disk diffusion and classical agar dilution techniques are adequate to assess the resistance profile of CRE to fosfomycin.Keywords
This publication has 32 references indexed in Scilit:
- Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?Clinical Infectious Diseases, 2013
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Fosfomycin: an old—new antibioticClinical Microbiology and Infection, 2012
- Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion MethodsAntimicrobial Agents and Chemotherapy, 2011
- Adverse events associated with intravenous fosfomycinInternational Journal of Antimicrobial Agents, 2011
- In Vitro Activity of Fosfomycin against bla KPC -Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or ColistinAntimicrobial Agents and Chemotherapy, 2010
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal InfectionsClinical Infectious Diseases, 2008
- Target site penetration of fosfomycin in critically ill patientsJournal of Antimicrobial Chemotherapy, 2003
- Immunomodulatory effect of fosfomycin on human B-lymphocyte functionAntimicrobial Agents and Chemotherapy, 1993
- A Protein-Free Medium for Primary Isolation of the Gonococcus and MeningococcusExperimental Biology and Medicine, 1941